Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Immunordic ApS
APS
Active
CVR 43773070
Fruebjergvej 3, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Immunordic ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
1M
2M
2M
1M
2023
1M
2024
2M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
541
956
2.352
Staff expenses
-609
-974
-2.240
EBITDA
-69
-18
112
Depreciation & amort.
-9
-4
-28
EBIT
-78
-22
83
Net financials
-0
-1
-1
Profit before tax
-78
-23
82
Tax
-29
-31
375
Net profit
-49
8
-293
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
1.054
3.606
5.933
Equity
-9
899
606
Long-term debt
0
0
0
Short-term debt
935
2.286
4.169
Total debt
935
2.286
4.169
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
4.8%
This company
2023
2025
Soliditetsgrad
10.2%
This company
38.2%
Market median
-73% vs market
2023
2025
Egenkapitalforrentning
-48.3%
This company
18.4%
Market median
-362% vs market
2023
2025
Nettoresultatgrad (af bruttofortjeneste)
-12.4%
This company
2023
2025
Aktivomsætning (af bruttofortjeneste)
0.40×
This company
2023
2025
Gæld/egenkapital
8.79×
This company
0.62×
Market median
-1318% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-12 – 2023-12-31
View
PDF
More on Immunordic ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
